Skip to content Skip to sidebar Skip to footer

Newsletter

Ujjwal Maheshwari

Ujjwal Maheshwari is a Sydney-based financial writer at Stocks Down Under, where he has covered ASX and forex markets for over three years. He specialises in breaking down complex market developments into clear, accessible analysis for everyday investors.

Bachelor of Commerce (Finance), University of New South Wales (UNSW)

605 articles published

Biotech Stocks

Neuren Pharmaceuticals (ASX:NEU) Surges 6% on US$700m DAYBUE Target: Time to Buy?

DAYBUE royalties could climb fast if US targets land Neuren Pharmaceuticals (ASX: NEU) jumped 6% on Wednesday after its US partner, Acadia Pharmaceuticals, shared big news at the J.P. Morgan Healthcare Conference. Acadia now expects DAYBUE sales to hit US$700 million by 2028, sending Neuren shares to around A$20.47. The stock has climbed more than…

ByUjjwal MaheshwariJanuary 15, 20260Comments

Mining Stocks

European Lithium (ASX: EUR) Surges 50% as Greenland Pilot Plant Kicks Off: Is It a Buying Opportunity?

European Lithium surges on Greenland Tanbreez milestones European Lithium (ASX: EUR) has climbed roughly 50% from its lows, trading around A$0.26. The catalyst? Big progress at Critical Metals Corp (NASDAQ: CRML), where European Lithium holds a huge stake. Pilot plant construction started on January 7, 2026, and the company just ordered a US$1 million mobile…

ByUjjwal MaheshwariJanuary 14, 20260Comments

Biotech Stocks

NeuroScientific (ASX:NSB) Reports 75% Response Rate in Crohn’s Trial: Is This Stem Cell Stock a Buy?

NeuroScientific jumps on early Crohn’s stem cell results NeuroScientific Biopharmaceuticals (ASX: NSB) surged 43% on Tuesday after announcing promising early results from its stem cell program. Three out of four patients achieved a clinical response in a Special Access Program for fistulising Crohn's disease. The company's StemSmart therapy showed a 75% success rate in treating one…

ByUjjwal MaheshwariJanuary 14, 20260Comments

Rare Earths Stocks

Lynas (ASX:LYC) CEO Amanda Lacaze Steps Down After 12 Years: Buy the Dip or Take Profits?

Lynas CEO Amanda Lacaze steps down after 12 years Lynas Rare Earths (ASX: LYC) shares are in focus after the company announced that CEO Amanda Lacaze will retire after 12 years in the role. Shares initially jumped 3% on Tuesday before settling up around 2.4% at A$15.14 as investors weighed what this means for the…

ByUjjwal MaheshwariJanuary 14, 20260Comments

Healthcare Stocks

Singular Health (ASX:SHG) Gains FDA Clearance for Cloud Imaging Platform: Is This MedTech a Buy Now?

Singular Health secures FDA clearance for US rollout Singular Health Group (ASX: SHG) grabbed investor attention on Tuesday after the company announced FDA 510(k) clearance for its 3DICOM MD Cloud platform. Shares surged as high as A$0.30 in early trade, representing a 15% intraday gain, before profit-taking pulled the stock back to close at A$0.26.…

ByUjjwal MaheshwariJanuary 14, 20260Comments

Mining Stocks

iTech Minerals (ASX:ITM) Surges 33% on Antimony Drill Results: Is It a Buy Now?

iTech Minerals Surges on High-Grade Antimony Drill Results iTech Minerals (ASX: ITM) surged 33 per cent on Monday to A$0.064 after the company released drill results that confirmed gold and antimony mineralisation at its Reynolds Range Project in the Northern Territory. The stock had been languishing near all-time lows, so this move suggests investors are…

ByUjjwal MaheshwariJanuary 13, 20260Comments

Healthcare Stocks

EBR Systems (ASX:EBR) Surges 7.6% on Q4 Momentum: Time to Buy Before Full US Launch?

EBR Systems Gains Momentum Ahead of 2026 US Launch EBR Systems (ASX: EBR) is building serious momentum as it moves closer to a full US commercial launch in 2026. Shares jumped 7.6 per cent on Monday to AUD 1.06, up from a previous close of AUD 0.98, as investors responded to strong Q4 adoption numbers.…

ByUjjwal MaheshwariJanuary 13, 20260Comments

Energy Stocks

Tamboran Resources (ASX:TBN) Slips 5% Despite Hiring US Shale Veteran: Is This a Buying Opportunity?

Tamboran Resources Names US Shale Veteran as CEO Tamboran Resources (ASX: TBN) has appointed Todd Abbott as its new CEO, effective Thursday, 15 January 2026, signalling a shift from exploration to full-scale development. Abbott brings more than 25 years of US shale experience, having held senior roles at Seneca Resources, Marathon Oil, and Pioneer Natural…

ByUjjwal MaheshwariJanuary 13, 20260Comments

Defence Stocks

PWR Holdings (ASX:PWH) Wins $13.5M Defence Contract: Time to Buy the Aerospace Pivot?

PWR Holdings Lands $13.5m US Defence Follow-On Contract PWR Holdings (ASX: PWH) surged nearly 10 per cent on Monday after the company announced a A$13.5 million (US$9.1 million) follow-on contract with the US Government. This is PWR's second deal with American defence agencies in less than a year, building directly on the initial order announced…

ByUjjwal MaheshwariJanuary 13, 20260Comments

Gold Stocks

Alkane Resources (ASX:ALK) Hits 5-Year High After 188% Rally: Time to Buy or Take Profits?

Alkane Resources: A Strong Buy After 188% Rally? Alkane Resources (ASX: ALK) jumped 11 per cent last week to reach its highest price in five years. The rally came after the company reported strong production numbers for the December quarter. Over the past 12 months, the stock has soared 188 per cent, making it one…

ByUjjwal MaheshwariJanuary 12, 20260Comments

the Kick-ass Multipurpose WordPress Theme

Ujjwal Maheshwari

Neuren Pharmaceuticals (ASX:NEU) Surges 6% on US$700m DAYBUE Target: Time to Buy?

European Lithium (ASX: EUR) Surges 50% as Greenland Pilot Plant Kicks Off: Is It a Buying Opportunity?

NeuroScientific (ASX:NSB) Reports 75% Response Rate in Crohn’s Trial: Is This Stem Cell Stock a Buy?

Lynas (ASX:LYC) CEO Amanda Lacaze Steps Down After 12 Years: Buy the Dip or Take Profits?

Singular Health (ASX:SHG) Gains FDA Clearance for Cloud Imaging Platform: Is This MedTech a Buy Now?

iTech Minerals (ASX:ITM) Surges 33% on Antimony Drill Results: Is It a Buy Now?

EBR Systems (ASX:EBR) Surges 7.6% on Q4 Momentum: Time to Buy Before Full US Launch?

Tamboran Resources (ASX:TBN) Slips 5% Despite Hiring US Shale Veteran: Is This a Buying Opportunity?

PWR Holdings (ASX:PWH) Wins $13.5M Defence Contract: Time to Buy the Aerospace Pivot?

Alkane Resources (ASX:ALK) Hits 5-Year High After 188% Rally: Time to Buy or Take Profits?

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Ujjwal Maheshwari

Stocks in Spotlight

Add Your Heading Text Here